Fig. 2: Key elements for successful clinical implementation of DNA methylation biomarkers in liquid biopsies.

Successful clinical implementation requires careful selection of an appropriate liquid biopsy source, paired with an optimized biomarker discovery approach and standardized targeted analyses. Emphasizing standardization, optimization and quality control across all stages increase the chances of developing robust biomarker tests that can be validated in clinical trials, demonstrating clinical utility and enabling eventual clinical implementation.